Chemocentryx (CCXI) Misses Q1 EPS by 3c

Chemocentryx (NASDAQ: CCXI) reported Q1 EPS of ($0.27), $0.03 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

You May Also Be Interested In

• Microsoft invests $1.5 bln in Abu Dhabi AI firm G42, takes board seat
• UBS Upgrades Rivian Automotive Inc (RIVN) to Neutral, 'More balanced at current levels'
• McDonald's (MCD) PT Lowered to $297 at Citi